Safety and tolerability of sacubitril/valsartan in chronic heart failure and reduced ejection fraction: Results from the open-label extension of the PARADIGM-HF study.

ABSTRACT:

SUBMITTER: Senni M 

PROVIDER: S-EPMC12482840 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature